CYP2C8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.512800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.210800E-01
Normal-vs-Stage2
2.273600E-01
Normal-vs-Stage3
8.358200E-01
Normal-vs-Stage4
3.237000E-01
Stage1-vs-Stage2
5.559200E-01
Stage1-vs-Stage3
3.982000E-01
Stage1-vs-Stage4
3.533000E-01
Stage2-vs-Stage3
2.497000E-01
Stage2-vs-Stage4
4.396600E-03
Stage3-vs-Stage4
7.145800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.734610E-01
Normal-vs-AfricanAmerican
5.706600E-01
Normal-vs-Asian
9.972400E-01
Caucasian-vs-AfricanAmerican
9.771800E-01
Caucasian-vs-Asian
6.852200E-02
AfricanAmerican-vs-Asian
4.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.295370E-01
Normal-vs-Female
7.827000E-01
Male-vs-Female
2.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.436400E-01
Normal-vs-Age(41-60Yrs)
7.002400E-01
Normal-vs-Age(61-80Yrs)
7.938200E-01
Normal-vs-Age(81-100Yrs)
4.438600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.231800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.598600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.032600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.429600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.572000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.731600E-01
Normal-vs-Daily Drinker
8.938800E-01
Normal-vs-Weekly Drinker
2.139600E-01
Normal-vs-Occasional Drinker
8.626800E-01
Normal-vs-Social Drinker
7.440600E-01
Non Drinker-vs-Daily Drinker
3.053000E-01
Non Drinker-vs-Weekly Drinker
1.312990E-01
Non Drinker-vs-Occasional Drinker
3.418000E-01
Non Drinker-vs-Social Drinker
3.907400E-01
Daily Drinker-vs-Weekly Drinker
1.509390E-01
Daily Drinker-vs-Occasional Drinker
9.082400E-01
Daily Drinker-vs-Social Drinker
7.300800E-01
Weekly Drinker-vs-Occasional Drinker
1.973990E-01
Weekly Drinker-vs-Social Drinker
1.069790E-01
Occasional Drinker-vs-Social Drinker
8.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.031990E-02
Normal-vs-Grade 2
7.991300E-04
Normal-vs-Grade 3
8.436100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.926400E-02
Grade 1-vs-Grade 3
3.267800E-01
Grade 1-vs-Grade 4
1.031990E-02
Grade 2-vs-Grade 3
5.019800E-01
Grade 2-vs-Grade 4
7.991300E-04
Grade 3-vs-Grade 4
8.436100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.277400E-01
Normal-vs-NonDiabetic
8.022200E-01
Diabetic-vs-NonDiabetic
3.544400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.510800E-01
Normal-vs-NoPancreatitis
8.262200E-01
Pancreatitis-vs-NoPancreatitis
1.303040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.362000E-01
Normal-vs-N1
1.918030E-01
N0-vs-N1
6.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.590200E-01
Normal-vs-TP53-NonMutant
2.238300E-02
TP53-Mutant-vs-TP53-NonMutant
2.040600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
